DocMorris seen up as German prescription sales lift Q2 revenue
15/07/2026 07:52
BUZZ-DocMorris seen up as German prescription sales lift Q2 revenue ** Shares in DocMorris DOCM.S are up 2.8% in Julius Baer pre-market indications after the online pharmacy reported a 15% rise in Q2 preliminary external revenue
** Germany prescription revenue rose 46% in the quarter, supported by a significant rise in new customers
** "Sales of prescription drugs (Rx) are gaining strong momentum," Zuercher Kantonalbank says
** DocMorris says Q2 adjusted EBITDA is expected to improve further from Q1, helped by operational and marketing efficiency
** The stock is up 70% year-to-date
(Reporting by Kira Britten)
Recent news on DocMorris AG
See all newsBrief: Docmorris AG Revenue And Adjusted EBITDA Guidance For 2026 Increased
Swiss stocks - Factors to watch on October 15
Brief: Docmorris Announces Final Conversion Price And Issue Size Of Its New Convertible Bonds Due 2031
Brief: Docmorris Successfully Completes The Private Placement Of Convertible Bonds Due 2031
Brief: Docmorris AG Convertible Bond Books Covered Throughout Bookbuilding Range, Says Bookrunner